Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target von Timmerman, Luika A., Holton, Thomas, Yuneva, Mariia, Louie, Raymond J., Padró, Mercè, Daemen, Anneleen, Hu, Min, Chan, Denise A., Ethier, Stephen P., van ‘t Veer, Laura J., Polyak, Kornelia, McCormick, Frank, Gray, Joe W.

Volltext

Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer von Lee, Joyce V., Housley, Filomena, Yau, Christina, Nakagawa, Rachel, Winkler, Juliane, Anttila, Johanna M., Munne, Pauliina M., Savelius, Mariel, Houlahan, Kathleen E., Van de Mark, Daniel, Hemmati, Golzar, Hernandez, Grace A., Zhang, Yibing, Samson, Susan, Baas, Carole, Kok, Marleen, Esserman, Laura J., van ‘t Veer, Laura J., Rugo, Hope S., Curtis, Christina, Klefström, Juha, Matloubian, Mehrdad, Goga, Andrei

Volltext

Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity von Wolf, Denise M, Lenburg, Marc E, Yau, Christina, Boudreau, Aaron, van 't Veer, Laura J

Volltext

Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance von Stejskal, Pavel, Goodarzi, Hani, Srovnal, Josef, Hajdúch, Marián, van 't Veer, Laura J, Magbanua, Mark Jesus M

Volltext

Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis von van den Broek, Alexandra J, Schmidt, Marjanka K, van 't Veer, Laura J, Tollenaar, Rob A E M, van Leeuwen, Flora E

Volltext

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies von Wolf, Denise M., Yau, Christina, Wulfkuhle, Julia, Brown-Swigart, Lamorna, Gallagher, Rosa I., Lee, Pei Rong Evelyn, Zhu, Zelos, Magbanua, Mark J., Sayaman, Rosalyn, O’Grady, Nicholas, Basu, Amrita, Delson, Amy, Coppé, Jean Philippe, Lu, Ruixiao, Braun, Jerome, Asare, Smita M., Sit, Laura, Matthews, Jeffrey B., Perlmutter, Jane, Hylton, Nola, Liu, Minetta C., Pohlmann, Paula, Symmans, W. Fraser, Rugo, Hope S., Isaacs, Claudine, DeMichele, Angela M., Yee, Douglas, Berry, Donald A., Pusztai, Lajos, Petricoin, Emanuel F., Hirst, Gillian L., Esserman, Laura J., van 't Veer, Laura J.

Volltext

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age von Piccart, Martine, van 't Veer, Laura J, Poncet, Coralie, Lopes Cardozo, Josephine M N, Delaloge, Suzette, Pierga, Jean-Yves, Vuylsteke, Peter, Brain, Etienne, Vrijaldenhoven, Suzan, Neijenhuis, Peter A, Causeret, Sylvian, Smilde, Tineke J, Viale, Giuseppe, Glas, Annuska M, Delorenzi, Mauro, Sotiriou, Christos, Rubio, Isabel T, Kümmel, Sherko, Zoppoli, Gabriele, Thompson, Alastair M, Matos, Erika, Zaman, Khalil, Hilbers, Florentine, Fumagalli, Debora, Ravdin, Peter, Knox, Susan, Tryfonidis, Konstantinos, Peric, Aleksandra, Meulemans, Bart, Bogaerts, Jan, Cardoso, Fatima, Rutgers, Emiel J T

Volltext

Integrating Imaging and Circulating Tumor DNA Features for Predicting Patient Outcomes von Magbanua, Mark Jesus M, Li, Wen, van 't Veer, Laura J

Volltext

Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanoma von Curl, Patti, Vujic, Igor, van 't Veer, Laura J, Ortiz-Urda, Susana, Kahn, James G

Volltext

Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers von Hilbers, Florentine S., Poncet, Coralie, Tryfonidis, Konstantinos, Viale, Giuseppe, Delaloge, Suzette, Pierga, Jean-Yves, Brain, Etienne G. C., Rubio, Isabel T., Thompson, Alastair M., Rutgers, Emiel J. T., Piccart, Martine J., van ’t Veer, Laura J., Cardoso, Fatima

Volltext

Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients von van den Broek, Alexandra J, Schmidt, Marjanka K, van ’t Veer, Laura J, Oldenburg, Hester S A, Rutgers, Emiel J, Russell, Nicola S, Smit, Vincent T. H. B M, Voogd, Adri C, Koppert, Linetta B, Siesling, Sabine, Jobsen, Jan J, Westenend, Pieter J, van Leeuwen, Flora E, Tollenaar, Rob A. E M

Volltext

Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial von Parker, Barbara A., Shatsky, Rebecca A., Schwab, Richard B., Wallace, Anne M., Wolf, Denise M., Hirst, Gillian L., Brown-Swigart, Lamorna, Esserman, Laura J., van ’t Veer, Laura J., Ghia, Emanuela M., Yau, Christina, Kipps, Thomas J.

Volltext

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial von Johansson, Annelie, Dar, Huma, van 't Veer, Laura J, Tobin, Nicholas P, Perez-Tenorio, Gizeh, Nordenskjöld, Anna, Johansson, Ulla, Hartman, Johan, Skoog, Lambert, Yau, Christina, Benz, Christopher C, Esserman, Laura J, Stål, Olle, Nordenskjöld, Bo, Fornander, Tommy, Lindström, Linda S

Volltext

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers von van den Broek, Alexandra J, van 't Veer, Laura J, Hooning, Maartje J, Cornelissen, Sten, Broeks, Annegien, Rutgers, Emiel J, Smit, Vincent T H B M, Cornelisse, Cees J, van Beek, Mike, Janssen-Heijnen, Maryska L, Seynaeve, Caroline, Westenend, Pieter J, Jobsen, Jan J, Siesling, Sabine, Tollenaar, Rob A E M, van Leeuwen, Flora E, Schmidt, Marjanka K

Volltext

predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer von Knauer, Michael, Mook, Stella, Rutgers, Emiel J. T, Bender, Richard A, Hauptmann, Michael, van de Vijver, Marc J, Koornstra, Rutger H. T, Bueno-de-Mesquita, Jolien M, Linn, Sabine C, van 't Veer, Laura J

Volltext

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer von Lee, Joyce V., Housley, Filomena, Yau, Christina, Nakagawa, Rachel, Winkler, Juliane, Anttila, Johanna M., Munne, Pauliina M., Savelius, Mariel, Houlahan, Kathleen E., Van de Mark, Daniel, Hemmati, Golzar, Hernandez, Grace A., Zhang, Yibing, Samson, Susan, Baas, Carole, Kok, Marleen, Esserman, Laura J., van ‘t Veer, Laura J., Rugo, Hope S., Curtis, Christina, Klefström, Juha, Matloubian, Mehrdad, Goga, Andrei

Volltext

Correction: Cost-Effectiveness Of Treatment Strategies for BRAF-Mutated Metastatic Melanoma von Curl, Patti, Vujic, Igor, van 't Veer, Laura J, Ortiz-Urda, Susana, Kahn, James G

Volltext

Tamoxifen therapy benefit for patients with 70-gene signature high and low risk von van ‘t Veer, Laura J., Yau, Christina, Yu, Nancy Y., Benz, Christopher C., Nordenskjöld, Bo, Fornander, Tommy, Stål, Olle, Esserman, Laura J., Lindström, Linda Sofie

Volltext

Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry von Huilgol, Yash S., Keane, Holly, Shieh, Yiwey, Hiatt, Robert A., Tice, Jeffrey A., Madlensky, Lisa, Sabacan, Leah, Fiscalini, Allison Stover, Ziv, Elad, Acerbi, Irene, Che, Mandy, Anton-Culver, Hoda, Borowsky, Alexander D., Hunt, Sharon, Naeim, Arash, Parker, Barbara A., van ‘T Veer, Laura J., Esserman, Laura J.

Volltext

MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue von Sapino, Anna, Roepman, Paul, Linn, Sabine C, Snel, Mireille H.J, Delahaye, Leonie J.M.J, van den Akker, Jeroen, Glas, Annuska M, Simon, Iris M, Barth, Neil, de Snoo, Femke A, van ’t Veer, Laura J, Molinaro, Luca, Berns, Els M.J.J, Wesseling, Jelle, Riley, Lee B, Anderson, David, Nguyen, Bichlien, Cox, Charles E

Volltext